Vascular remodeling, macro- and microvessels: Therapeutic implications

Blood Pressure

Volumn 18, Issue 5, 2009, Pages 242-246

  Rizzoni, Damiano ^a   Muiesan, Maria Lorenza ^a   Porteri, Enzo ^a   Ciuceis, Carolina De ^a   Boari, Gianluca E M ^a   Salvetti, Massimo ^a   Paini, Anna ^a   Rosei, Enrico Agabiti ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Microcirculation

Indexed keywords

AMLODIPINE; ATENOLOL; CANDESARTAN; CILAZAPRIL; HYDROCHLOROTHIAZIDE; INDAPAMIDE; IRBESARTAN; ISRADIPINE; LISINOPRIL; LOSARTAN; NIFEDIPINE; PERINDOPRIL; VALSARTAN;

ANGIOGENESIS; ANTIHYPERTENSIVE THERAPY; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTERY RESISTANCE; BLOOD VESSEL; BLOOD VESSEL INJURY; HUMAN; HYPERTENSION; MICROCIRCULATION; MICROVASCULATURE; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROGNOSIS; PULSE PRESSURE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SHORT SURVEY; SYSTOLIC BLOOD PRESSURE; VASCULAR RESISTANCE; VASOCONSTRICTION; VISCOELASTICITY;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD VESSELS; CALCIUM CHANNEL BLOCKERS; HUMANS; HYPERTENSION; VASCULAR RESISTANCE;

EID: 70450187036     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.1080/08037050903254923     Document Type: Short Survey

References (22)

1. Boutouyrie P, Laurent S, Briet M. Importance of arterial stiffness as cardiovascular risk factor for future development of new type of drugs. Fundam Clin Pharmacol. 2008;22:241-246.
2. Mahmud A, Feely J. Spurious systolic hypertension of youth: Fit young men with elastic arteries. Am J Hypertens. 2003; 16:229-232.
3. Laurent S, Cockcroft J, van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al., on behalf of the European Network for Non-invasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: Methodological issues and clinical applications. Eur Heart J. 2006;27:2588-2605.
4. Agabiti-Rosei E, Mancia G, O'Rourke MF, Roman MJ, Safar ME, Smulyan H, et al. Central blood pressure measurements and antihypertensive therapy: A consensus document. Hypertension. 2007;50:154-160.
5. McEniery CM, Yasmin, Hall IR, Qasem A, Wilkinson IB, Cockcroft JR; ACCT Investigators. Normal vascular aging: Differential effects on wave refection and aortic pulse wave velocity: The Anglo-Cardiff Collaborative Trial (ACCT). Am Coll Cardiol. 2005;46:1753-1760.
6. Mulvany MJ, Aalkjaer C. Structure and function of small arteries. Physiol Rev. 1990;70:921-971.
7. Schiffrin EL. Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment. Am J Hypertens. 2004;17(12 Pt 1):1192-1200.
8. Rizzoni D, Porteri E, Castellano M, Bettoni G, Muiesan ML, Muiesan P, et al. vascular hypertrophy and remodeling in secondary hypertension. Hypertension. 1996;28:785-790.
9. Heagerty AM, Aalkjaaer C, Bund SJ, Korsgaard N, Mulvany MJ. Small artery structure in hypertension. Dual process of remodeling and growth. Hypertension. 1993;21:391-397.
10. Rizzoni D, Palombo C, Porteri E, Muiesan ML, Kozàkovà M, La Canna G, et al. Relationships between coronary vasodilator capacity and small artery remodeling in hypertensive patients. J Hypertens. 2003;21:625-632.
11. Rizzoni D, Porteri E, Boari GEM, De Ciuceis C, Sleiman I, Muiesan ML, et al. Prognostic signifcance of small artery structure in hypertension. Circulation. 2003;108:2230-2235.
12. Safar ME, Rizzoni D, Blacher J, Muiesan ML, Agabiti-Rosei E. Macro and microvasculature in hypertension: Therapeutic aspects. J Hum Hypertens. 2008;22:590-595.
13. Westerhof BE, van den Wijngaard JP, Murgo JP, Westerhof N. Location of a refection site is elusive: Consequences for the calculation of aortic pulse wave velocity. Hypertension. 2008;52:478-483.
14. Mitchell GF, Conlin PR, Dunlap ME, Lacourcière Y, Arnold JM, Ogilvie RI, et al. Aortic diameter, wall stiffness, and wave refection in systolic hypertension. Hypertension. 2008;51:105-111.
15. Boari GE, Rizzardi N, De Ciuceis C, Platto C, Paiardi S, Porteri E, et al. Determinants of the structure of resistance-sized arteries in hypertensive patients. Blood Press. 2008; 17:204-211.
16. Hashimoto J, Aikawa T, Imai Y. Large artery stiffening as a link between cerebral lacunar infarction and renal albumin-uria. Am J Hypertens. 2008;21:1304-1309.
17. Agabiti-Rosei E, Heagerty AM, Rizzoni D. Effects of antihy-pertensive treatment on small artery remodelling. J Hypertens. 2009;27:1107-1114.
18. Savoia C, Touyz RM, Endemann DH, Pu Q, Ko EA, De Ciuceis C, et al. Angiotensin receptor blocker added to previous antihypertensive agents on arteries of diabetic hypertensive patients. Hypertension. 2006;48:271-277.
19. London GM, Asmar RG, O'Rourke MF, Safar ME, and Reason Project Investigators, Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: Comparison with atenolol. J Am Coll Cardiol. 2004;43:92-99.
20. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, et al.; CAFE Investigators; Anglo-Scandinavian Cardiac Outcomes Trial Investigators; CAFE Steering Committee and Writing Committee; et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: Principal results of the Conduit Artery Function Evaluation (CAFÉ) study. Circulation. 2006;113:1213-1225.
21. De Luca N, Asmar R, London GM, O'Rourke MF, Safar ME. REASON Project Investigators. Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects. J Hypertens. 2004;22:1623-1630. (Pubitemid 39037615)
22. Morgan T, Lauri J, Bertram D, Anderson A. Effect of different antihypertensive drug classes on central aortic pressure. Am J Hypertens. 2004;7:118-123.